Physician

Adrian Alexander Mancheno Revelo, MD

According to 2025 Medicare claims, Adrian Revelo, MD (NPI: 1255627477) practices family practice in the Burlington, NC market, with the plurality of this provider's patient population coming from Alamance, NC. This provider's primary affiliated billing organization is PIEDMONT HEALTH SERVICES, INC. (NPI: 1164526109; TIN: 560952737) and primary practice location at 27217-2863. Revelo is affiliated with the C3 MSSP LLC (ACO ID: A5344), participating under the MSSP model.

Revelo's data goes back to 2015 and runs through 2024. Part D data shows 1,795 prescription claims across 208 beneficiaries totaling $236,692 in drug costs, led by Ozempic (Semaglutide). DME data shows 117 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $64,714 and ending at $236,692. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,718 to $95.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$581K$1.2M2015 Drug cost: $64,714 (USD; Tot_Drug_Cst)2016 Drug cost: $119,108 (USD; Tot_Drug_Cst)2017 Drug cost: $498,903 (USD; Tot_Drug_Cst)2018 Drug cost: $1,162,994 (USD; Tot_Drug_Cst)2019 Drug cost: $409,946 (USD; Tot_Drug_Cst)2020 Drug cost: $662,922 (USD; Tot_Drug_Cst)2021 Drug cost: $440,984 (USD; Tot_Drug_Cst)2022 Drug cost: $394,303 (USD; Tot_Drug_Cst)2023 Drug cost: $367,154 (USD; Tot_Drug_Cst)2024 Drug cost: $236,692 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151051,299$64,714
20161161,588$119,108
20171291,376$498,903
20181721,751$1,162,994
20192252,665$409,946
20202272,847$662,922
20212382,917$440,984
20222532,905$394,303
20232492,403$367,154
20242081,795$236,692

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$775K$1.6M2015 Medicare payment: $320 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $203 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $46 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $215 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $242 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,550,266 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R23$320
2016N/R11$203
2017N/RN/RN/R
2018N/R11$46
2019N/R14$215
2020N/R45$242
2021N/RN/RN/R
2022N/RN/RN/R
2023117117$1,550,266
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OzempicSemaglutide311,445$49,829
EliquisApixaban302,024$40,060
JardianceEmpagliflozin191,721$34,010
Spiriva HandihalerTiotropium Bromide23870$14,300
Lantus SolostarInsulin Glargine,hum.Rec.Anlog271,148$2,952

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Adrian Alexander Mancheno Revelo, MD?

Tedicare shows public-source Medicare data for Adrian Alexander Mancheno Revelo, MD (NPI 1255627477), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrian Alexander Mancheno Revelo, MD have ACO affiliation data?

Adrian Alexander Mancheno Revelo, MD is shown with ACO affiliation data for C3 MSSP LLC (MSSP, ACO ID A5344).

What billing organization is linked to Adrian Alexander Mancheno Revelo, MD?

Adrian Alexander Mancheno Revelo, MD is linked to PIEDMONT HEALTH SERVICES, INC. (billing NPI 1164526109) in the available physician profile data.

Does Adrian Alexander Mancheno Revelo, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.